Skip to contentClarengateINTELLIGENCE
Companies/10076821

Evox Therapeutics Limited

Research and experimental development on biotechnology · Oxford

ActiveUnited KingdomIncorporated 2016Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

No electronic account filings

No extracted electronic accounts are available in our records.

Registered details

10076821
Status
Active
Type
Private Limited Company
Incorporated
2016-03-22
Jurisdiction
Registered office
1MEDAWAR CENTRE 2ND FLOOR, EAST BUILDING, OXFORD, OXFORDSHIRE, OX4 4HG, UNITED KINGDOM

Classification

1 SIC codes
72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

2 matched grants
Total Body Nuclear Imaging for the Development of NanotheranosticsActive
EPSRC · Research Grant · 2026-01-05 – 2031-01-05 · with 20 other participants
£9,980,399
whole project
King'S College LondonleadAstral SystemsAstrazeneca UK LimitedCentre for Process Innovation CPI (UK)Cyclife Aquila NuclearEVOX Therapeutics LtdGE HealthcareInnoMedica Holding AGInternational Iberian Nanotechnology LaboratoryJohnson & Johnson (United Kingdom)McMaster UniversityMediso Medical Imaging Systems LtdNanotechnology Industries AssociationNational Nuclear Laboratory (Nnl)National PET Imaging Platform (NPIP)Perceptive DiscoveryPerspective TherapeuticsPrecision X-ray IrradiationSiemens Healthcare (Germany)Stream Bio LtdVacV Biotherapeutics
Exosome therapy for rare paediatric disorder Argininosuccinic AciduriaLead
Innovate UK · Collaborative R&D · 2019-02-01 – 2021-03-31 · with 1 other participant
£827,244
awarded
Evox Therapeutics Limitedlead£827,244